No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Genenta Science, Maintains $25 Price Target
Genenta Science Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 635.29% HC Wainwright & Co. → $25 Reiterates Buy → Buy 06/29/2023 341.18% Roth MKM → $15 Assume
Analysts Conflicted on These Healthcare Names: Cingulate Inc (CING) and Genenta Science SpA Sponsored ADR (GNTA)
Press Release: Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinica
Genenta Science Advances Biotech Endeavors
Genenta Science Announces ADS Sales Agreement
No Data
T-24Century : something isn't right
Moomoo Lily : Hi mooer, are you referring to data errors on the chart? Could you please provide me with the specific details of the errors, so that we can further verify the situation?